A commentary on the original research article: 'Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers'. Of note, the predictor selection process, the cross-validation method, along with the lack of final testing of the developed model with a separated data set may mask overfitting, overestimating performance metrics.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317071 | PMC |
| http://dx.doi.org/10.1136/jitc-2021-003044 | DOI Listing |
Publication Analysis
Top Keywords
analysis predicting
8
predicting pembrolizumab
8
pembrolizumab response
8
response patients
8
patients advanced
8
advanced rare
8
letter editor
4
editor radiomics
4
radiomics analysis
4
rare cancers
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!